Cargando…
Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI a...
Autores principales: | Pradhan, Swetalina, Madke, Bhushan, Neema, Shekhar, Kabra, Poonam, Singh, Adarsh Lata, Yadav, Sangita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751712/ https://www.ncbi.nlm.nih.gov/pubmed/35068505 http://dx.doi.org/10.4103/ijd.IJD_649_16 |
Ejemplares similares
-
Less-known clinical signs in dermatology
por: Pradhan, Swetalina, et al.
Publicado: (2016) -
Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology
por: Pradhan, Swetalina, et al.
Publicado: (2016) -
Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland
por: von Both, Ulrich, et al.
Publicado: (2021) -
Psoriasis: A Primer for General Physicians
por: Dasari, Shalini, et al.
Publicado: (2023) -
Cutaneous Munchausen Syndrome by Proxy: A Diagnostic Challenge for Dermatologist
por: Sirka, Chandra S., et al.
Publicado: (2018)